PCV50 Cost Effectiveness Analysis of Azilsartan Medoxomil and Chlorthalidone Fixed Dose Combination Therapy for Treatment of Hypertension
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.653
https://www.valueinhealthjournal.com/article/S1098-3015(12)00718-8/fulltext
Title :
PCV50 Cost Effectiveness Analysis of Azilsartan Medoxomil and Chlorthalidone Fixed Dose Combination Therapy for Treatment of Hypertension
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00718-8&doi=10.1016/j.jval.2012.03.653
First page :
A121
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
129